|
How many volunteers were present at the Congress? : |
150 |
|
Delegates from which countries presented in the congress? : |
china,india,USA,Iran, Argentina, Japan, Taiwan, hong kong, Russia, Australia, Italy, south korea, UK |
|
Were the delegates of any other organizations present in the congress? : |
Yes |
|
If yes, please write the names of the organizations in the box : |
China, Japan, UK |
|
What were the responses to your talking points? Were specific questions or concerns raised? : |
My present was interesting for audience because of using tissue engineering and stem cells for spinal cord injury treatment. |
|
If you met staff members, please list their full names & positions. : |
dr.nandini gokulchandran(India), prof.gustavo A.Moviglia (argantina), Alok sharma(india), wise young (USA), Russel J Andrews(USA),Ping Wu(USA) |
|
Please inform us if there are any follow up actions we need to talk with the members of the congress : |
prof.gustavo A.Moviglia (argantina) director of centre for tissue, engineering and cellular therapy research, Argentina. He is chairman in the next IANR congress in Argentina. His email is
movinglia.gustavo@maimonides.edu Dr Hoshangh Saberi is other professor in Iran that attended in this congress as a chairman. His email is saberih@tums.ac.ir
you can talk about cell therapy for spinal cord injured people and treatment of them. |
|
Your experiences about the travel processes(Providing ticket, accommodation,...) : |
all process were done by passenger agency and our groups. we attended in this congress with 6 people from TUMS and tehran university, our viza were group viza for 7days. |
|
Please give a briefing of your own observations and outcomes of the congress: : |
My study is based on neural tissue engineering, in this congress, many surgeons attended and I obtained new insight about spinal cord injury treatment specifically in human. They used stem cells from different sources and injected in spinal cord injured site. The results were interesting and patients after cell transplantation could walk. I talk about the big problem in the cell therapy that is low survival of cells in the region of injury and for solving this problem I talk about tissue engineering and application of scaffold for cell seeding on them. It was interesting for them specially surgeons. |